Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
4.860
+0.010 (0.21%)
At close: Apr 28, 2026, 4:00 PM EDT
4.860
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:29 PM EDT
Absci Revenue
In the year 2025, Absci had annual revenue of $2.80M, down -38.24%. Absci had revenue of $650.00K in the quarter ending December 31, 2025, a decrease of -2.26%.
Revenue (ttm)
$2.80M
Revenue Growth
-38.24%
P/S Ratio
267.79
Revenue / Employee
$20,000
Employees
140
Market Cap
743.68M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CorMedix | 311.71M |
| Rigel Pharmaceuticals | 294.28M |
| Zevra Therapeutics | 106.47M |
| Prothena Corporation | 9.68M |
| Aclaris Therapeutics | 7.83M |
| Adlai Nortye | 5.00M |
| Prime Medicine | 4.63M |
| Ocugen | 4.41M |
ABSI News
- 5 days ago - Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026 - GlobeNewsWire
- 12 days ago - Absci Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 20 days ago - Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Absci Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results - GlobeNewsWire
- 7 weeks ago - Absci Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer - GlobeNewsWire